Your browser doesn't support javascript.
loading
Diabetes mellitus por mutación en el gen de glucokinasa: caso clínico / Diabetes mellitus caused by a mutation of glucokinase gene: report of an affected family
Pollak C, Felipe; Lagos L, Marcela; Santos M, José L; Poggi, Helena; Urzúa C, Abraham; Rumié C, Hana.
Affiliation
  • Pollak C, Felipe; Pontificia Universidad Católica de Chile. Facultad de Medicina. Departamento de Nutrición, Diabetes y Metabolismo. Santiago. CL
  • Lagos L, Marcela; Pontificia Universidad Católica de Chile. Facultad de Medicina. Departamento de Nutrición, Diabetes y Metabolismo. Santiago. CL
  • Santos M, José L; Pontificia Universidad Católica de Chile. Facultad de Medicina. Departamento de Nutrición, Diabetes y Metabolismo. Santiago. CL
  • Poggi, Helena; Pontificia Universidad Católica de Chile. Facultad de Medicina. Departamento de Nutrición, Diabetes y Metabolismo. Santiago. CL
  • Urzúa C, Abraham; Pontificia Universidad Católica de Chile. Facultad de Medicina. Departamento de Nutrición, Diabetes y Metabolismo. Santiago. CL
  • Rumié C, Hana; Pontificia Universidad Católica de Chile. Facultad de Medicina. Departamento de Nutrición, Diabetes y Metabolismo. Santiago. CL
Rev. méd. Chile ; 145(9): 1203-1207, set. 2017. tab, graf
Article in Es | LILACS | ID: biblio-902608
Responsible library: CL1.1
ABSTRACT
Maturity-Onset Diabetes of the Young (MODY) refers to a heterogeneous group of monogenic diabetes. Unlike other types of MODY characterized by genetic defects in transcription factors, MODY 2 is triggered by metabolic alterations caused by mutations of glucokinase (GCK), the first enzyme of the glycolytic pathway. We report a three-generation Chilean family with multiple cases affected with this disease. The index case is a patient who presented severe neonatal hyperglycemia (831 mg/dl, without ketosis) requiring continuous infusion of insulin, which was suspended after 48 hours with normalization of blood glucose. Subsequently, continuous glucose monitoring at 4 months of age revealed 47% of tissue glucose levels above 140 mg/dl, with fasting glucose levels between 120 and 166 mg/dl. The genetic analysis revealed a previously reported mutation in heterozygous state of the GCK gene (c.148C>T; p.His50Tyr). This mutation was also identified in more than one affected relative in the last two generations, with a transmission pattern suggestive of dominant inheritance. GCK gene sequencing led to a correct molecular diagnosis of MODY 2 while bioinformatic analysis indicated the possible molecular causes of the enzyme dysfunction. The knowledge of the molecular diagnosis allowed an adequate medical treatment for this disease.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: LILACS Main subject: Diabetes Mellitus, Type 2 / Glucokinase / Mutation Type of study: Observational_studies / Prognostic_studies Limits: Humans / Male / Newborn Language: Es Journal: Rev. méd. Chile Journal subject: MEDICINA Year: 2017 Document type: Article Affiliation country: Chile Country of publication: Chile

Full text: 1 Collection: 01-internacional Database: LILACS Main subject: Diabetes Mellitus, Type 2 / Glucokinase / Mutation Type of study: Observational_studies / Prognostic_studies Limits: Humans / Male / Newborn Language: Es Journal: Rev. méd. Chile Journal subject: MEDICINA Year: 2017 Document type: Article Affiliation country: Chile Country of publication: Chile